-
NTLA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Intellia Therapeutics (NTLA)
Company Profile
Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 202.79 mm | 202.79 mm | 202.79 mm | 202.79 mm | 202.79 mm | 202.79 mm |
Cash burn (monthly) | (no burn) | 3.13 mm | 45.48 mm | 44.52 mm | 28.40 mm | 29.07 mm |
Cash used (since last report) | n/a | 6.62 mm | 96.14 mm | 94.11 mm | 60.03 mm | 61.46 mm |
Cash remaining | n/a | 196.17 mm | 106.64 mm | 108.67 mm | 142.76 mm | 141.33 mm |
Runway (months of cash) | n/a | 62.7 | 2.3 | 2.4 | 5.0 | 4.9 |
13F holders | Current |
---|---|
Total holders | 294 |
Opened positions | 66 |
Closed positions | 53 |
Increased positions | 125 |
Reduced positions | 65 |
13F shares | Current |
---|---|
Total value | 1.15 tn |
Total shares | 101.45 mm |
Total puts | 820.01 k |
Total calls | 1.03 mm |
Total put/call ratio | 0.8 |
Largest owners | Shares | Value |
---|---|---|
ARK Investment Management | 12.54 mm | $146.17 bn |
BlackRock | 10.86 mm | $126.60 bn |
Vanguard | 10.19 mm | $118.82 bn |
STT State Street | 5.21 mm | $60.70 bn |
MS Morgan Stanley | 3.81 mm | $44.48 bn |
REGN Regeneron Pharmaceuticals | 3.70 mm | $43.18 bn |
CMTDF Sumitomo Mitsui Trust | 2.99 mm | $34.89 bn |
Nikko Asset Management Americas | 2.99 mm | $34.89 bn |
Citadel Advisors | 2.49 mm | $29.08 bn |
Geode Capital Management | 2.39 mm | $27.86 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
29 Jan 25 | Muna Bhanji | Common Stock | Sell | Dispose S | No | Yes | 9.97 | 265 | 2.64 k | 19,468 |
3 Jan 25 | David Lebwohl | Common Stock | Sell | Dispose S | No | No | 12.18 | 9,557 | 116.40 k | 87,666 |
3 Jan 25 | Derek Hicks | Common Stock | Sell | Dispose S | No | No | 12.18 | 6,502 | 79.19 k | 59,878 |
3 Jan 25 | Laura Sepp-Lorenzino | Common Stock | Sell | Dispose S | No | No | 12.18 | 8,966 | 109.21 k | 77,388 |